Verano Holdings VRNO
OTC VRNO
$6.21 +0.16 (+2.64%)
As of: Aug 21, 2026 · 3:59 PM EDT

Verano Holdings (VRNO) Change in Accured Expenses (2021 - 2026)

Verano Holdings (VRNO) posted quarterly Change in Accured Expenses of -$15.7 million for Q1 2026, down 74.1% year-over-year from -$60.7 million in Q1 2025, and down 489.04% quarter-over-quarter from $4.0 million in Q4 2025.

Verano Holdings (VRNO) Change in Accured Expenses (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has reported Change in Accured Expenses for 6 consecutive years, with -$15.7 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Accured Expenses fell 74.1% year-over-year to -$15.7 million; the TTM figure through Mar 2026 stood at -$12.2 million (up 31.07% YoY), while the FY2025 annual figure was -$5.5 million, up 67.69% from the prior year.
  • Change in Accured Expenses eased to -$15.7 million in Q1 2026 per VRNO's latest filing, from $4.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $32.2 million in Q4 2022 and bottomed at -$18.0 million in Q3 2022.
  • Historically, Change in Accured Expenses has averaged -$1.5 million across 5 years, with a median of -$5.2 million in 2023.
  • On a YoY basis, Change in Accured Expenses climbed as much as 203.91% in 2022 and fell as far as 1092.79% in 2022.
  • Verano Holdings' Change in Accured Expenses stood at $32.2 million in 2022, then slipped by 19.29% to $26.0 million in 2023, then slumped by 139.64% to -$10.3 million in 2024, then jumped by 139.21% to $4.0 million in 2025, then plunged by 489.04% to -$15.7 million in 2026.
  • Business Quant data shows VRNO's Change in Accured Expenses at -$15.7 million in Q1 2026, $4.0 million in Q4 2025, and -$1.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 82.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 142.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -219.00 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -4.00 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -8.50 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Verano Holdings 449.04 Mn 363.85 Mn 99.70 Mn 157,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 157,000.00
Jun 30, 2026 157,000.00
Mar 31, 2026 -15.72 Mn
Mar 31, 2026 -15.72 Mn
Dec 31, 2025 4.04 Mn
Dec 31, 2025 4.04 Mn
Sep 30, 2025 -1.43 Mn
Sep 30, 2025 -1.43 Mn
Jun 30, 2025 939,000.00
Jun 30, 2025 939,000.00
Mar 31, 2025 -9.03 Mn
Mar 31, 2025 -9.03 Mn
Dec 31, 2024 -10.31 Mn
Dec 31, 2024 -10.31 Mn
Sep 30, 2024 -1.61 Mn
Sep 30, 2024 -1.61 Mn
Jun 30, 2024 3.29 Mn
Jun 30, 2024 3.29 Mn
Mar 31, 2024 -8.33 Mn
Mar 31, 2024 -8.33 Mn